This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.
Influenza activity had been decreasing across the Region until week 4/2023, following a peak at week 51/2022, but has fluctuated around 25% since week 6/2023 due to increased type B virus circulation.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 February - 5 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza and influenza A(H5N1) , Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, poliomyelitis, Marburg virus disease and the Earthquakes in Türkiye, Syria.
Seasonal influenza activity had been decreasing across the Region after a peak at week 51/2022 until week 4/2023 and increased again up to week 7/2023 due to increased type B virus circulation.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 February 2023 and includes updates on the Earthquake in Türkiye and Syria, COVID-19, Influenza A (H5N1), Group A streptococcal infection, and cholera.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
Seasonal influenza activity is still widespread in the EU/EEA, with an increase in positivity noted between week 5 and 7/2023 related to increased type B virus circulation.
Seasonal influenza activity is still widespread in the EU/EEA, with an increase in positivity in sentinel primary care starting from week 5/2023 related to increased type B virus circulation.